Company / EPS (Diluted)
PharmaCyte Biotech, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.80
FY2025
5-year range
-$4.23 / -$0.22
FY2021-FY2025
Trend
-718.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -718% YoY in FY2025, a notable deviation from the 8-year average annual change of -49%.
Based on SEC 10-K filings.
-1.80 in FY2025.
Declined from $-0.27 to $-1.80 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 718.2% year-over-year.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.80 | -718.2% |
| FY2024 | -$0.22 | +18.5% |
| FY2023 | -$0.27 | +89.0% |
| FY2022 | -$2.45 | +42.1% |
| FY2021 | -$4.23 | - |
| FY2020 | $0.00 | +100.0% |
| FY2019 | -$0.01 | +0.0% |
| FY2018 | -$0.01 | +0.0% |
| FY2017 | -$0.01 | +80.0% |
| FY2016 | -$0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026